| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 2872 | 5-Methyl-2,4-bis[(trimethylsilyl)oxy]pyrimidine |
2872.0100: 100 mg per vial
Please inquire for customized filling and bulk quantities.
|
|
Precursor 2 for [18F]FMAU
(2′-deoxy-2′-[18F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil) |
||
| Caution, very sensitive to moisture! | ||
| Molar Mass: 270.48 | ||
| C11H22N2O2Si2 | ||
| [7288-28-0] | ||
| Colourless solid packaged in dark glass crimp cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H and 13C NMR spectra |
||
|
Chemical Name: CA index name: Pyrimidine, 5-methyl-2,4-bis[(trimethylsilyl)oxy]- |
||
|
Synonymes: 2,4-Bis(trimethylsiloxy)-5-methylpyrimidine; 2,4-Bis(trimethylsilyl)-5-methyluracil; 2,4-Bis-O-(trimethylsilyl)thymine; O,O′-Bis(trimethylsilyl)thymine; Bis(O-trimethylsilyl)thymine |
||
|
Literature: 1. Mangner T.J. et al. Synthesis of 2′-deoxy-2′-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU, [18F]FIAU, as potential PET agents for imaging cellular proliferation. Nucl. Med. Biol. 2003, 30, 215-224. |
||
| 2. Buursma A.R. et al. 18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers. Nucl. Med. Commun. 2006, 27, 25-30. | ||
| 3. Alauddin M.M. et al. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol. Imaging 2004, 3, 76-84. | ||
| 4. Alauddin M.M. et al. Synthesis and evaluation of 2′-deoxy-2′-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. J. Nucl. Med. 2004, 45, 2063-2069 | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1